Cancer Cells Surface Proteins: New Immunotherapy Targets 2026
UCSF researchers found oncogenic protein Src on cancer cell surfaces, potentially creating new immunotherapy targets for hard-to-treat solid tumors.
By Priya Patel
immunotherapy
3 articles tagged "immunotherapy"
Camrelizumab Plus CAPOX Improves Survival in Gastric Cancer
Phase 3 trial shows camrelizumab plus CAPOX with maintenance therapy significantly improves overall survival vs CAPOX alone in HER2-negative gastric cancer.
Dual Checkpoint Inhibition in Adjuvant Renal Cell Carcinoma: Phase III Evidence for Durvalumab-Tremelimumab Combination
A phase III randomized controlled trial demonstrates statistically significant improvement in disease-free survival with adjuvant durvalumab plus tremelimumab in resectable renal cell carcinoma. The combination regimen represents a potential paradigm shift in postoperative management of high-risk RCC patients.